LawPlayer
My bookmarksSign up freeSign up free
Source

Commission Implementing Decision (EU) 2017/1281 of 13 July 2017 authorising the placing on the market of L-ergothioneine as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4844)

Commission Implementing Decision (EU) 2017/1281 of 13 July 2017 authorising the placing on the market of L-ergothioneine as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2017) 4844)

Implementing Decision (EU) 2017/1281 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Without prejudice to Directive 2002/46/EC, L-ergothioneine as specified in Annex I may be placed on the Union market as a novel food ingredient to be used in food supplements intended for the general population, excluding infants and young children, and pregnant and lactating women, for the uses defined and at the maximum levels established in Annex II.

Article 2

Open ↗

The designation of L-ergothioneine authorised by this Decision on the labelling of the foodstuffs shall be ‘L-ergothioneine’.

Article 3

Open ↗

This Decision is addressed to Tetrahedron, 14, avenue de l'Opéra, 75001 Paris, France.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I SPECIFICATIONS OF L-ERGOTHIONEINE Definition Chemical name (IUPAC) (2S)-3-(2-thioxo-2,3-dihydro-1 H -imidazol-4-yl)-2-(trimethylammonio)-propanoate Chemical formula C 9 H 15 N 3 O 2 S Molecular mass 229,3 Da CAS No 497-30-3 IUPAC: International Union for Pure and Applied Chemistry Specifications Parameter Specification Method Appearance White powder Visual Optical rotation [α] D ≥ (+) 122° (c = 1, H 2 0)  ( 1 ) Polarimetry Chemical purity ≥ 99,5 % HPLC [Eur. Ph. 2.2.29] ≥ 99 % 1H-NMR Identification Compliant with the structure 1H-NMR C: 47,14 ± 0,4 %   H: 6,59 ± 0,4 %   N: 18,32 ± 0,4 % Elemental analysis Total residual solvents (methanol, ethyl acetate, isopropanol, ethanol) [Eur. Ph. 01/2008:50400] < 1 000 ppm Gas chromatography [Eur. Ph. 01/2008:20424] Loss on drying Internal standard < 0,5 % [Eur. Ph. 01/2008:20232] Impurities < 0,8 % HPLC/GPC or 1H-NMR Heavy metals  ( 2 )  ( 3 ) Lead < 3 ppm ICP/AES (Pb, Cd) Atomic fluorescence (Hg) Cadmium < 1 ppm Mercury < 0,1 ppm Microbiological specifications  ( 2 ) Total viable aerobic count (TVAC) ≤ 1 × 10 3 CFU/g [Eur. Ph. 01/2011:50104] Total yeast and mould count (TYMC) ≤ 1 × 10 2 CFU/g Escherichia coli Absent in 1 g Eur. Ph.: European Pharmacopoeia; 1H-NMR: proton nuclear magnetic resonance; HPLC: high-performance liquid chromatography; GPC: gel permeation chromatography; ICP/AES: Inductively coupled plasma atomic emission spectroscopy; CFU: colony-forming units. ( 1 )   Lit. [α] D = (+) 126,6° (c = 1, H 2 0) ( 2 )   Analyses conducted on each batch ( 3 )   Maximum levels in accordance with Commission Regulation (EC) No 1881/2006 ( OJ L 364, 20.12.2006, p. 5 ).

ANNEX IISupplementary provisions

Open ↗

ANNEX II AUTHORISED USES OF L-ERGOTHIONEINE Food category Maximum levels Food supplements as defined in Directive 2002/46/EC 30 mg/day for general population (excluding pregnant and lactating women) 20 mg/day for children older than 3 years

Other acts of the same type
Council Implementing Decision (CFSP) 2017/634 of 3 April 2017 implementing Decision 2014/932/CFSP concerning restrictive measures in view of the situation in YemenCouncil Decision (EU) 2017/657 of 3 April 2017 on the conclusion on behalf of the European Union of the Agreement between the European Union and the Principality of Liechtenstein on supplementary rules in relation to the instrument for financial support for external borders and visa, as part of the Internal Security Fund for the period 2014 to 2020Council Decision (EU) 2017/674 of 3 April 2017 establishing the position to be adopted on behalf of the European Union within the eighth meeting of the Conference of the Parties to the Rotterdam Convention as regards the amendments of Annex III to the Rotterdam Convention on the Prior Informed Consent Procedure for certain hazardous chemicals and pesticides in international tradeCouncil Decision (EU) 2017/710 of 3 April 2017 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex XX (Environment) to the EEA Agreement (CO2 Emissions)Council Decision (CFSP) 2017/621 of 31 March 2017 amending Decision (CFSP) 2015/1333 concerning restrictive measures in view of the situation in LibyaCommission Implementing Decision (EU) 2017/1013 of 30 March 2017 drawing up the standard reporting form referred to in Article 17 of Regulation (EC) No 561/2006 of the European Parliament and of the Council (notified under document C(2017) 1927) (Text with EEA relevance. )Council Decision (CFSP) 2017/607 of 29 March 2017 amending Decision 2011/173/CFSP concerning restrictive measures in view of the situation in Bosnia and HerzegovinaCommission Decision (EU) 2017/652 of 29 March 2017 on the proposed citizens' initiative entitled ‘Minority SafePack — one million signatures for diversity in Europe’ (notified under document C(2017) 2200)Council Decision (EU) 2017/609 of 27 March 2017 on the conclusion, on behalf of the European Union and its Member States, of a Protocol to the Euro-Mediterranean Agreement establishing an Association between the European Community and its Member States, of the one part, and the Republic of Lebanon, of the other part, to take account of the accession of the Republic of Croatia to the European UnionCouncil Implementing Decision (EU) 2017/617 of 27 March 2017 on the launch of automated data exchange with regard to DNA data in GreeceCouncil Implementing Decision (EU) 2017/618 of 27 March 2017 on the launch of automated data exchange with regard to vehicle registration data in DenmarkCouncil Decision (EU) 2017/715 of 27 March 2017 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex II (Technical Regulations, Standards, Testing and Certification) and Annex XVII (Intellectual Property) to the EEA Agreement (Paediatric Regulation)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next